West Pharma (WST) Reports Preliminary Q1 EPS of 88c, Tops Views; Boosts FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) expects first-quarter Adjusted Diluted EPS to be $0.83, compared to $0.60 in the first quarter of 2011, on sales growth of approximately 7% (9% excluding currency effects). The Street sees EPS of 65 cents.
The Company attributed the improvement primarily to broad-based increases in pharmaceutical packaging sales.
The Company increased its guidance for Adjusted Diluted EPS for the year 2012 to between $2.50 and $2.67 per share, including between $0.07 and $0.10 of first quarter growth that is not expected to reoccur. The Company's prior guidance for 2012 was for Adjusted Diluted EPS of between $2.37 and $2.55.
The Street is currently looking for EPS of $2.47.
The Company attributed the improvement primarily to broad-based increases in pharmaceutical packaging sales.
The Company increased its guidance for Adjusted Diluted EPS for the year 2012 to between $2.50 and $2.67 per share, including between $0.07 and $0.10 of first quarter growth that is not expected to reoccur. The Company's prior guidance for 2012 was for Adjusted Diluted EPS of between $2.37 and $2.55.
The Street is currently looking for EPS of $2.47.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Full Truck Alliance (YMM) Tops Q2 EPS by 10c; beats on guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
